← All Kaya Holdings, INC filings

Kaya Holdings, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
KAYS
Kaya Holdings, INC
10-K/A: Kaya Holdings Reports Discontinued Operations and Ongoing Concerns in Amended 10-K Filing
Kaya Holdings' amended 10-K filing reveals discontinued retail cannabis operations, a shift towards psychedelic medicine, and substantial doubt about the company's ability to continue as a going concern.
OTC.Pink
KAYS
Kaya Holdings, INC
10-K: Kaya Holdings Faces Financial Headwinds Despite Psychedelic Venture; Suspends Payroll, Eyes Restructuring
Kaya Holdings, a holding company in the wellness sector, reports a net loss for 2024 and suspends payroll due to capital constraints, despite progress in its psychedelic treatment center operations.
OTC.Pink
KAYS
Kaya Holdings, INC
10-K/A: Kaya Holdings Files Amended 10-K to Correct Certification Date Error
Kaya Holdings has filed an amendment to its 2023 Form 10-K solely to correct an error in the date of the executive certification.
OTC.Pink
KAYS
Kaya Holdings, INC
10-K: Kaya Holdings Eyes Psychedelic Market with Flagship Treatment Center, Reports Mixed Financial Results
Kaya Holdings is transitioning towards psychedelic therapeutics with the planned opening of 'The Sacred Mushroom' treatment center, while reporting a net income for 2023 primarily due to derivative liability adjustments.